We, the People Did Next To Nothing
By John Kendall Hawkins,
CounterPunch
| 10. 14. 2022
Ken Burns’s recently released film, The US and the Holocaust, is, as anticipated, an excellent addition to his growing library of documentaries on American culture and history. As the film’s title implies, Burns is delving into the less-investigated role of the American government in responding to the events that became known as the Holocaust. It attempts to mollify Jews and the PBS middle class of pledge donors by offering up example after example of how the US government failed to intervene in the growing humanitarian crisis in a Europe inflamed by Adolf Hitler’s spreading venomous nationalism, as well as painting a picture of indifference from the American public who steadfastly shrugged as reports of atrocities came through that were treated like the ravings of conspiracy theorists.
Holocaust is a 3-part series is told with the usual black-and-white period photos and the informed commentary of historians who use the passive voice. These include Guy Stern, Deborah Lipstadt, Rebecca Erbelding, Eva Geiringer, as well as Daniel Mendelsohn, author of the The Lost: A Search for Six of Six Million(2006). The...
Related Articles
By Jacob M. Apel, The Baltimore Sun | 08.16.2024
By Neha Kondaveeti, The Austin Chronicle | 08.16.2024
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...